V. Grosso

Clinical practice guidelines for reporting nail fold videocapillaroscopy: a Delphi consensus on behalf of the Italian Society of Rheumatology study group on capillaroscopy

Francesca Ingegnoli, Debora Pireddu, Elena Platania, Rossella De Angelis et autres

OBJECTIVES: In clinical practice, standardised reporting of nailfold videocapillaroscopy (NVC) findings is lacking, making the interpretation and comparison of results difficult. We aimed to achieve a national consensus on how to describe NVC findings in routine clinical practice. METHODS: A web-based Delphi …

it, jp, be (code pays fourni par la source)

The Role of Anti-MDA5 Antibodies in Rapidly Progressive Interstitial Lung Disease: A Case Report and Literature Review

V. Grosso, Francisca Bulai, Alice Cerato, Cristina Olivero et autres

BACKGROUND: Anti-melanoma Differentiation-associated Gene 5 (aMDA5) antibody-associated Rapidly Progressive Interstitial Lung Disease (RP-ILD) is a rare and potentially fatal condition. CASE PRESENTATION: This case report describes a 78-year-old male who presented with a 10-day history of fever, cough, and asthenia. Despite initial …

it (code pays fourni par la source)

SAT0622 ROLE OF PREGNANCY IN FLARE AND PROGRESSION INTO DEFINED RHEUMATIC DISEASE IN WOMEN WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE: RESULTS FROM A MONOCENTRIC OBSERVATIONAL COHORT

Francesca Motta, Véronique Laure Ramoni, Roberto Felice Caporali, V. Grosso et autres

it (code pays fourni par la source)

AB0225 Clinical outcomes of treatment with golimumab in seropositive and seronegative rheumatoid arthritis patients in real-life settings. data from italian register gisea

Florenzo Iannone, Roberto Felice Caporali, V. Grosso, Ennio Giulio Favalli et autres

it, es (code pays fourni par la source)

SAT0193 Early discontinuation of first line biological treatment with etanercept in patients with rheumatoid arthritis: results from the italian gisea registry

Marco Sebastiani, Andreina Manfredi, Florenzo Iannone, Elisa Gremese et autres

it, jp, us (code pays fourni par la source)

Randomized controlled trials and real-world data: differences and similarities to untangle literature data

Sara M. Monti, V. Grosso, Monica Todoerti

Randomized controlled trials (RCTs) represent the gold-standard of medical evidence to assess the efficacy and safety of therapeutic interventions. However, the need to minimize bias and ensure the correct design to explore the study aims often affects the generalizability of results. As …

it (code pays fourni par la source)

Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.

MARIA MANARA, Roberto Felice Caporali, Ennio Giulio Favalli, V. Grosso et autres

OBJECTIVES: We aimed to provide data on golimumab real-life use in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) from a multicentre observational registry of Northern Italy. METHODS: We extracted data of patients who started treatment with golimumab from October …

it (code pays fourni par la source)

Two‐year persistence of golimumab as second‐line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real‐life data from the LORHEN registry

Ennio Giulio Favalli, LUIGI SINIGAGLIA, Andrea Becciolini, V. Grosso et autres

OBJECTIVES: To evaluate the 2-year retention rate of golimumab compared with etanercept and adalimumab as second-line biologic agent in rheumatoid arthritis (RA) patients who failed a previous tumor necrosis factor inhibitor (TNFi). METHODS: Data on RA patients treated with a second-line subcutaneous …

it (code pays fourni par la source)

FRI0215 Comparative efficacy and retention rate of tocilizumab and tnf inhibitors used in combination with methotrexate as first-line biologic therapy in rheumatoid arthritis: data from a multicentre observational registry

Ennio Giulio Favalli, Martina Biggioggero, Fabiola Atzeni, Enrico Fusaro et autres

np, it (code pays fourni par la source)

AB0332 Golimumab Efficacy in Rheumatoid Arthritis after Conventional and Biological Treatment: Data from The Italian Lorhen Registry

V. Grosso, Roberto Gorla, Piercarlo Sarzi‐Puttini, Fabiola Atzeni et autres

it (code pays fourni par la source)

AB0226 One Year Experience of A Bdmard Spacing Protocol in Real Life Rheumatoid Arthritis Patients

Monica Todoerti, Sara M. Monti, V. Grosso, Francesca De Nard et autres

it (code pays fourni par la source)

SAT0225 Screening for Pulmonary Arterial Hypertension in Systemic Sclerosis Patients: Single Center Real-Life Performance of The Detect Algorithm

Francesca De Nard, Veronica Codullo, V. Grosso, A. Gallarati et autres

it (code pays fourni par la source)